{"Mice bearing the orthotopic model were treated starting from day 21 after NB cell implant; mice with the pseudo-metastatic model received the first treatment 4h after NB cell injection. These therapeutic schedules were designed to test the effects of our targeted formulations against both established and pseudo-metastatic preclinical models of human NB, as described [16,19]. Animals were treated i.v. once a week for 3 weeks with untargeted (SL[DXR]) or peptide-targeted SL[DXR] (5mg/kg). Scrambled peptide-functionalized liposomes were used as a control, and in every experiment a group of control mice received HEPES-buffered saline. Survival times were used as the main criterion for determining treatment efficacy. In the orthotopic model, time-dependent anti-tumor activity was also evaluated by bioluminescence imaging (BLI) and X-ray analyses. For this purpose, the GI-LI-N cell line was infected with a retrovirus expressing the firefly luciferase gene, as previously reported [17]; luciferase activity of retrovirally-transduced cells was visualized in vivo by BLI (IVIS Caliper Life Sciences, Hopkinton, MA) after a 10min incubation with 150μg/mL of d-luciferin (Caliper Life Sciences), as described [17]. X-ray analysis was superimposed to the luminescence for a better visualization of the tumors.": "Los ratones que llevan el modelo ortotópico fueron tratados a partir del día 21 después del implante celular NB; los ratones con el modelo pseudometastático recibieron el primer tratamiento 4h después de la inyección celular NB. Estos programas terapéuticos fueron diseñados para probar los efectos de nuestras formulaciones dirigidas contra modelos preclínicos establecidos y pseudometastáticos de NB humana, como se describe [16,19]. Los animales fueron tratados i.v. una vez a la semana durante 3 semanas con SL[DXR] o SL[DXR] péptidos dirigidos a objetivos específicos. Los liposomas péptidos péptidos scrambleados fueron utilizados como control, y en cada experimento un grupo de ratones de control recibieron análisis de solución salina HEPES-buffered. Los tiempos de supervivencia fueron utilizados como criterio principal para determinar la eficacia del tratamiento. En el modelo ortotópico, la actividad antitumoral dependiente del tiempo también fue evaluada por bioluminiscencia (BLI) como se describe en la Directiva de la vida útil."}